Calithera Biosciences | DEFM14A: Definitive proxy statement relating to merger or acquisition
Jun 5, 2023 17:16 ET
Calithera Biosciences | DEFA14A: Others
May 19, 2023 20:50 ET
Calithera Biosciences | 15-12G: Notice of termination of registration of a class of securities under Section 12(g) (and amendment thereto)
Mar 14, 2023 16:15 ET
Calithera Biosciences | S-8 POS: S-8 POS
Mar 14, 2023 16:13 ET
Calithera Biosciences | S-8 POS: S-8 POS
Mar 14, 2023 16:12 ET
Calithera Biosciences | S-8 POS: S-8 POS
Mar 14, 2023 16:11 ET
Calithera Biosciences | S-8 POS: S-8 POS
Mar 14, 2023 16:10 ET
Calithera Biosciences | S-8 POS: S-8 POS
Mar 14, 2023 16:09 ET
Calithera Biosciences | S-8 POS: S-8 POS
Mar 14, 2023 16:08 ET
Calithera Biosciences | S-8 POS: S-8 POS
Mar 14, 2023 16:07 ET
Calithera Biosciences | S-8 POS: S-8 POS
Mar 14, 2023 16:06 ET
Calithera Biosciences | S-8 POS: S-8 POS
Mar 14, 2023 16:04 ET
Calithera Biosciences | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
Mar 14, 2023 16:02 ET
Calithera Biosciences | DEFA14A: Others
Jan 25, 2023 06:10 ET
Calithera Biosciences | 8-K: Current report
Jan 25, 2023 06:09 ET
Calithera Biosciences | DEFA14A: Others
Jan 9, 2023 08:07 ET
Calithera Biosciences | 8-K: Current report
Jan 9, 2023 08:05 ET
Calithera Biosciences | 8-K: Calithera Biosciences Reports Third Quarter 2022 Financial Results and Business Update
Nov 14, 2022 16:09 ET
Calithera Biosciences | 8-K: Current report
Sep 29, 2022 16:02 ET
Calithera Biosciences | NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB
Aug 16, 2022 17:22 ET
No Data
No Data